Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer

PURPOSE: O(6)-methylguanine DNA methyltransferase (MGMT)-silenced tumors reveal sensitivity to temozolomide (TMZ), which may be enhanced by PARP inhibitors. Approximately 40% of colorectal cancer has MGMT silencing and we aimed to measure antitumoral and immunomodulatory effects from TMZ and olapari...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecchini, Michael, Zhang, Janie Y., Wei, Wei, Sklar, Jeffrey, Lacy, Jill, Zhong, Minghao, Kong, Yong, Zhao, Hongyu, DiPalermo, Jassim, Devine, Lesley, Stein, Stacey M., Kortmansky, Jeremy, Johung, Kimberly L., Bindra, Ranjit S., LoRusso, Patricia, Schalper, Kurt A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305782/
https://www.ncbi.nlm.nih.gov/pubmed/37387791
http://dx.doi.org/10.1158/2767-9764.CRC-23-0045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305782/
https://www.ncbi.nlm.nih.gov/pubmed/37387791
http://dx.doi.org/10.1158/2767-9764.CRC-23-0045

Ejemplares similares